Published in Arch Dermatol on June 01, 1978
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol (2005) 1.10
Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon. Clin Rheumatol (2010) 0.90
Urticarial vasculitis. Br Med J (Clin Res Ed) (1983) 0.89
Urticarial vasculitis and syndromes in association with connective tissue diseases. Ann Rheum Dis (1991) 0.81
Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol (1968) 16.77
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Pyoderma gangrenosum: a review of 86 patients. Q J Med (1985) 3.08
Gonorrhea. Ann Intern Med (1970) 2.95
Gonorrhea--diagnosis and treatment. Obstet Gynecol (1972) 2.91
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Therapy for incubating syphilis. Effectiveness of gonorrhea treatment. JAMA (1971) 2.27
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc (1995) 2.12
Treatment for early syphilis and reactivity of serologic tests. JAMA (1972) 2.07
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma. Arch Dermatol (2001) 1.53
Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc (1976) 1.50
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother (1979) 1.48
Tests for treponemal antibody in CSF. Arch Intern Med (1978) 1.48
Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol (1986) 1.47
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
The rectal culture as a test of cure of gonorrhea in the female. J Infect Dis (1972) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum (1976) 1.38
Episodic angioedema associated with eosinophilia. N Engl J Med (1984) 1.38
Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol (1983) 1.36
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
Effect of a nitro-imidazole on primary experimental syphilis in rabbits. Br J Vener Dis (1966) 1.24
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
Antinuclear antibodies in primary biliary cirrhosis. Lancet (1984) 1.17
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Variations in serum concentrations of penicillin after injections of aqueous procaine penicillin G with and without oral probenecid. Br J Vener Dis (1971) 1.14
Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc (1982) 1.12
Liposarcoma of the right atrium. J Ir Med Assoc (1972) 1.11
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
The sign of Leser-Trélat in a case of adenocarcinoma of the lung. J Am Acad Dermatol (2000) 1.10
Autobiographical memory and problem-solving strategies of parasuicide patients. Psychol Med (1992) 1.10
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol (1985) 1.09
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Direct immunofluorescence in pyoderma gangrenosum. Br J Dermatol (1983) 1.06
The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol (1982) 1.04
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
An unusual variant of lupus erythematosus or lichen planus. Br J Dermatol (1970) 1.01
Skin manifestations of pentazocine abuse. J Am Acad Dermatol (1980) 1.01
The fluorescent treponemal antibody absorbed (FTA-ABS) test beading phenomenon in connective tissue diseases. Mayo Clin Proc (1973) 1.00
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Herpes gestationis. New immunologic findings. Arch Dermatol (1974) 0.99
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Suspected skin malignancy: a comparison of diagnoses of family practitioners and dermatologists in 493 patients. Int J Dermatol (2001) 0.99
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis--possible pseudoglucagonoma syndrome. Br J Dermatol (1979) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol (1978) 0.97
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
Inflammatory macular atrophy: immunofluorescent and ultrastructural findings. J Am Acad Dermatol (1979) 0.95
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Problems with beaded fluorescence pattern in FTA-ABS test. J Am Vener Dis Assoc (1976) 0.95
The cutaneous immunopathology of necrobiosis lipoidica diabeticorum. Arch Dermatol (1988) 0.95
Direct immunofluorescence of normal skin in rheumatoid arthritis. Br J Rheumatol (1985) 0.94
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Cutaneous periarteritis nodosa: immunofluorescence studies. Arch Dermatol (1980) 0.93
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc (1974) 0.93
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Paraneoplastic pyoderma gangrenosum. Australas J Dermatol (1993) 0.92
Papulonecrotic tuberculid secondary to Mycobacterium bovis. Arch Dermatol (1978) 0.92
Coagulation abnormalities in rheumatoid disease. Arthritis Rheum (1977) 0.91
Pyoderma gangrenosum and monoclonal gammopathy. Arch Dermatol (1983) 0.91
Whole organisms and purified cell walls compared as immunosorbents for the detection of IgE antibodies to Staphylococcus aureus. J Immunol Methods (1984) 0.91
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
Skin cancer screening--a local experience. J Am Acad Dermatol (1987) 0.91
Pacemaker contact sensitivity. Contact Dermatitis (1984) 0.91
The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc (1984) 0.90
Cutaneous Mycobacterium malmoense infection in an immunocompromised patient. Int J Dermatol (1990) 0.90
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol (1977) 0.90
Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol (1975) 0.89
Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol (1983) 0.89